Cargando…
Breast‐conserving therapy shows better prognosis in mucinous breast carcinoma compared with mastectomy: A SEER population‐based study
BACKGROUND: Mucinous breast carcinoma (MBC) is a relatively rare pathological type of breast cancer. Compared with mastectomy in MBC, the effect and safety of breast‐conserving therapy (BCT) remains unclear. Therefore, we investigated the long‐term prognosis of BCT and mastectomy in T1‐2 stage mucin...
Autores principales: | Yu, Ping, Liu, Peng, Zou, Yutian, Xie, Xinhua, Tang, Hailin, Li, Na, Xie, Xiaoming, Ye, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402828/ https://www.ncbi.nlm.nih.gov/pubmed/32515157 http://dx.doi.org/10.1002/cam4.3202 |
Ejemplares similares
-
Breast-Conserving Therapy Versus Mastectomy in Young Breast Cancer Patients Concerning Molecular Subtypes: A SEER Population-Based Study
por: Yu, Ping, et al.
Publicado: (2020) -
Risk factors and survival outcomes in patients with breast cancer and lung metastasis: a population‐based study
por: Xiao, Weikai, et al.
Publicado: (2018) -
Predictive Nomogram of Subsequent Liver Metastasis After Mastectomy or Breast-Conserving Surgery in Patients With Nonmetastatic Breast Cancer
por: Yang, Anli, et al.
Publicado: (2021) -
Breast-Conserving Therapy Has Better Prognosis for Tumors in the Central and Nipple Portion of Breast Cancer Compared with Mastectomy: A SEER Data-Based Study
por: Wang, Jing, et al.
Publicado: (2021) -
Breast‐conserving therapy is associated with better survival than mastectomy in Early‐stage breast cancer: A propensity score analysis
por: Ji, Jiali, et al.
Publicado: (2022)